Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Systemic adverse events following rituximab therapy in patients with Graves' disease

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Manifesto for the current understanding and management of traumatic brain injury-induced hypopituitarism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Rapid changes in plasma androgens during insulin withdrawal in male type 1 (insulin-dependent) diabetics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Hypercalcemia after cosmetic oil injections: Unraveling Etiology, Pathogenesis, and Severity

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Complement split product C3c in saliva as biomarker for periodontitis and response to periodontal treatment

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Protein array-based companion diagnostics in precision medicine

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer
Rituximab (RTX) therapy has shown promising results in Graves' disease (GD), with or without ophthalmopathy. We examined the occurrence of adverse events in GD patients treated with RTX.
OriginalsprogEngelsk
TidsskriftJournal of Endocrinological Investigation
Vol/bind34
Udgave nummer7
Sider (fra-til)e163-7
ISSN0391-4097
DOI
StatusUdgivet - 2011

ID: 32712566